Interested in learning more about Tigermed? Please choose the forms below to submit on-line request or reach out to us via: marketing@tigermedgrp.com. Our representative will respond promptly.
Hangzhou Tigermed Consulting Co., Ltd
F18, Building A – Shengda Science Park
No.19 Jugong Road, Binjiang District, Hangzhou, China 310051
Tel: +86-571-28887227
We are committed to supporting our clients in their clinical development in the best possible way.
We are committed to supporting our clients in their clinical development in the best possible way.
We are committed to supporting our clients in their clinical development in the best possible way.
We are committed to supporting our clients in their clinical development in the best possible way.
We are committed to supporting our clients in their clinical development in the best possible way.
We are committed to supporting our clients in their clinical development in the best possible way.
Following the latest revision of China’s drug administration law from December 2019, drug life cycle management has become a key obligation for Marketing Authorization Holders (MAHs).
In this blog post, we will shortly outline the regulatory framework for orphan drug development in the USA and Europe, and then focus on recent developments and future prospects in China.
Learn what needs to be taken into account when planning to collect and use Real-World Data.
We are committed to supporting our clients in their clinical development in the best possible way.